VolitionRx Limited Files 8-K: Material Agreement & Other Events

Ticker: VNRX · Form: 8-K · Filed: Mar 26, 2025 · CIK: 93314

Sentiment: neutral

Topics: material-agreement, corporate-events, filings

TL;DR

VolitionRx signed a big deal, filed financials, and other stuff. Details light.

AI Summary

On March 24, 2025, VolitionRx Limited entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company also reported other events and filed financial statements and exhibits. VolitionRx Limited is incorporated in Delaware and its principal executive offices are located in Henderson, Nevada.

Why It Matters

This 8-K filing indicates significant corporate activity for VolitionRx Limited, including the execution of a material definitive agreement, which could impact its business operations and future financial performance.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, but the lack of specific details about the agreement introduces uncertainty regarding its impact.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by VolitionRx Limited?

The filing states that VolitionRx Limited entered into a material definitive agreement on March 24, 2025, but does not provide specific details about the agreement itself.

What other items are reported in this 8-K filing besides the material agreement?

In addition to the entry into a material definitive agreement, the filing also reports 'Other Events' and 'Financial Statements and Exhibits'.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on March 24, 2025.

Where are VolitionRx Limited's principal executive offices located?

VolitionRx Limited's principal executive offices are located at 1489 West Warm Springs Road, Suite 110, Henderson, Nevada, 89014.

What is VolitionRx Limited's state of incorporation?

VolitionRx Limited is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 26, 2025 regarding VOLITIONRX LTD (VNRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing